Utrecht Holdings Seed Fund and Graduate Ventures invest in Visualise.bio
We are very proud to announce a co-investment in Visualise Bio, a spin-off of the UU, a life science-based technology company developing automated sample preparation for high-resolution 3D microscopy.
Visualise Bio
At visualise.bio, we aim to make high-resolution 3D microscopy accessible and reliable, through automation and quality control solutions. We focus on expansion microscopy (ExM), with our goal to enable detailed and reproducible ExM for all.
Cresco Spine received FDA clearance for their Spring Distraction System!
Major milestone for our portfolio company Cresco Spine. More information about their FDA approval below:
Dutch biotech CryoCloud raises €2M to enhance machine learning for drug discovery
The company’s platform enables researchers to visualise and analyse protein structures at high resolution, reducing the time and cost of molecular imaging. Dutch biotech CryoCloud has secured a €2M Seed funding round to expand its cryo-electron microscopy SaaS platform, which aims to streamline drug development by automating complex structural biology workflows. The round was led by Barcelona-based […]
Phlox Therapeutics Secures New Funding to Advance RNA Therapies for Genetic Cardiomyopathies
Phlox Therapeutics raises 1.9M funding to develop RNA therapies for genetic laminopathies The investor syndicate includes ROM Utrecht Region, FIRST Fund, Amsterdam-UMC Ventures and UHSF Funds support preclinical development of Phox’s lead program Naarden, The Netherlands, 6 November 2024 – Phlox Therapeutics, a private biotechnology company focused on developing innovative RNA-based therapies for cardiomyopathies, […]
